Doctor profile · Federal record

Dr. Joel Gelfand, MD

Dermatology Physician (CMS: Dermatology) · Philadelphia, PA

  • NPI 1710902382
  • Accepts Medicare
  • MIPS 85.5 / 100 · 2023
  • 28 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
3400 Spruce Street, 2 Rhodes Pavilion
Philadelphia, PA 19104
(215) 662-2737
fax (215) 349-8339

Credentials & registration

NPPES · NUCC
NPI registered
July 2006 — 20 yrs on file
Profile last updated
February 18, 2011
Year of graduation
1998 — 28 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
Pennsylvania #MD071826L
Medicaid
PA #0019039370001

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1710902382. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
292
Distinct HCPCS
6
Medicare allowed
$19,844
HCPCS Description Services Patients Avg allowed
99214 Established patient office or other outpatient visit, 30-39 minutes 136 93 $101
17003 Destruction of precancer skin growth, 2-14 growths 55 13 $2
99213 Established patient office or other outpatient visit, 20-29 minutes 37 26 $69
17000 Destruction of precancer skin growth, 1 growth 28 20 $54
11102 Biopsy of related skin growth, first growth 19 18 $36
17110 Destruction of skin growth, 1-14 growths 17 15 $71

In context: peer comparison

Among 55 peers in Philadelphia Dermatology Physician, average services per provider: 169. This provider delivers 1.7× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$84,610
Transactions
114
Manufacturers
11
Payer (manufacturer) Industry Txns Amount
E.R. Squibb & Sons, L.L.C. 26 $18,078.80
Eli Lilly and Company 4 $13,950.00
Abbvie INC. 16 $12,056.26
Amgen INC. 9 $11,697.41
Leo Pharma INC. 4 $6,468.21
Novartis Pharmaceuticals Corporation 14 $6,293.52
Leo Pharma As 2 $5,385.00
Janssen Global Services, LLC 9 $5,106.43
Boehringer Ingelheim International GmbH 22 $3,370.29
Janssen Biotech, INC. 7 $2,154.84
Regeneron Pharmaceuticals, INC. 1 $49.69

By nature of payment

Consulting Fee
$65,366
Compensation for Services Other Than Consulting, Including Serving As Faculty or As A Speaker at A Venue Other Than A Continuing Education Program
$13,782
Travel and Lodging
$4,336
Food and Beverage
$1,126

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
245
Patients
33
Total drug cost
$2,203,618
Drug Type Claims Patients Total cost
Skyrizi Pen (Risankizumab-Rzaa) Brand 44 12 $865,278
Triamcinolone Acetonide Generic 35 21 $523
Tremfya (Guselkumab) Brand 31 0 $426,866
Skyrizi (Risankizumab-Rzaa) Brand 24 0 $506,106
Vtama (Tapinarof) Brand 21 0 $29,738
Humira Pen (Adalimumab) Brand 19 0 $135,083
Cosentyx Sensoready (2 Pens) (Secukinumab) Brand 18 0 $127,018
Clobetasol Propionate Generic 17 0 $1,266
Halobetasol Propionate Generic 13 0 $1,070
Otezla (Apremilast) Brand 12 0 $29,598

Frequently asked questions

Auto-generated from federal data
What is Dr. Joel Gelfand's medical specialty?
Dr. Joel Gelfand practices Dermatology Physician in Philadelphia, PA.
Where does Dr. Joel Gelfand practice?
Dr. Joel Gelfand practices at 3400 Spruce Street, Philadelphia, PA 19104. Office phone: 2156622737.
What is Dr. Joel Gelfand's NPI?
Dr. Joel Gelfand's National Provider Identifier (NPI) is 1710902382, issued by NPPES.
Does Dr. Joel Gelfand accept Medicare assignment?
Yes. Dr. Joel Gelfand accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Joel Gelfand commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.